1106 related articles for article (PubMed ID: 26755632)
1. Impact of Different Target Sequences on Type III CRISPR-Cas Immunity.
Maniv I; Jiang W; Bikard D; Marraffini LA
J Bacteriol; 2016 Jan; 198(6):941-50. PubMed ID: 26755632
[TBL] [Abstract][Full Text] [Related]
2. Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape.
Pyenson NC; Gayvert K; Varble A; Elemento O; Marraffini LA
Cell Host Microbe; 2017 Sep; 22(3):343-353.e3. PubMed ID: 28826839
[TBL] [Abstract][Full Text] [Related]
3. Recombination between phages and CRISPR-cas loci facilitates horizontal gene transfer in staphylococci.
Varble A; Meaden S; Barrangou R; Westra ER; Marraffini LA
Nat Microbiol; 2019 Jun; 4(6):956-963. PubMed ID: 30886355
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CRISPR-Cas system in clinical Staphylococcus epidermidis strains revealed its potential association with bacterial infection sites.
Li Q; Xie X; Yin K; Tang Y; Zhou X; Chen Y; Xia J; Hu Y; Ingmer H; Li Y; Jiao X
Microbiol Res; 2016 Dec; 193():103-110. PubMed ID: 27825477
[TBL] [Abstract][Full Text] [Related]
5. Survey of clustered regularly interspaced short palindromic repeats and their associated Cas proteins (CRISPR/Cas) systems in multiple sequenced strains of Klebsiella pneumoniae.
Ostria-Hernández ML; Sánchez-Vallejo CJ; Ibarra JA; Castro-Escarpulli G
BMC Res Notes; 2015 Aug; 8():332. PubMed ID: 26238567
[TBL] [Abstract][Full Text] [Related]
6. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids.
Jiang W; Maniv I; Arain F; Wang Y; Levin BR; Marraffini LA
PLoS Genet; 2013; 9(9):e1003844. PubMed ID: 24086164
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas systems exploit viral DNA injection to establish and maintain adaptive immunity.
Modell JW; Jiang W; Marraffini LA
Nature; 2017 Apr; 544(7648):101-104. PubMed ID: 28355179
[TBL] [Abstract][Full Text] [Related]
8. Viral diversity threshold for adaptive immunity in prokaryotes.
Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
[TBL] [Abstract][Full Text] [Related]
9. The CRISPR Spacer Space Is Dominated by Sequences from Species-Specific Mobilomes.
Shmakov SA; Sitnik V; Makarova KS; Wolf YI; Severinov KV; Koonin EV
mBio; 2017 Sep; 8(5):. PubMed ID: 28928211
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction.
Watson BNJ; Staals RHJ; Fineran PC
mBio; 2018 Feb; 9(1):. PubMed ID: 29440578
[TBL] [Abstract][Full Text] [Related]
11. Cooperation between Different CRISPR-Cas Types Enables Adaptation in an RNA-Targeting System.
Hoikkala V; Ravantti J; Díez-Villaseñor C; Tiirola M; Conrad RA; McBride MJ; Moineau S; Sundberg LR
mBio; 2021 Mar; 12(2):. PubMed ID: 33785624
[TBL] [Abstract][Full Text] [Related]
12. Friendly Fire: Biological Functions and Consequences of Chromosomal Targeting by CRISPR-Cas Systems.
Heussler GE; O'Toole GA
J Bacteriol; 2016 May; 198(10):1481-6. PubMed ID: 26929301
[TBL] [Abstract][Full Text] [Related]
13. Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems.
Silas S; Lucas-Elio P; Jackson SA; Aroca-Crevillén A; Hansen LL; Fineran PC; Fire AZ; Sánchez-Amat A
Elife; 2017 Aug; 6():. PubMed ID: 28826484
[TBL] [Abstract][Full Text] [Related]
14. Different modes of spacer acquisition by the Staphylococcus epidermidis type III-A CRISPR-Cas system.
Aviram N; Thornal AN; Zeevi D; Marraffini LA
Nucleic Acids Res; 2022 Feb; 50(3):1661-1672. PubMed ID: 35048966
[TBL] [Abstract][Full Text] [Related]
15. Role of CRISPR/cas system in the development of bacteriophage resistance.
Szczepankowska A
Adv Virus Res; 2012; 82():289-338. PubMed ID: 22420856
[TBL] [Abstract][Full Text] [Related]
16. Genetic characterization of antiplasmid immunity through a type III-A CRISPR-Cas system.
Hatoum-Aslan A; Maniv I; Samai P; Marraffini LA
J Bacteriol; 2014 Jan; 196(2):310-7. PubMed ID: 24187086
[TBL] [Abstract][Full Text] [Related]
17. Metagenomic reconstructions of bacterial CRISPR loci constrain population histories.
Sun CL; Thomas BC; Barrangou R; Banfield JF
ISME J; 2016 Apr; 10(4):858-70. PubMed ID: 26394009
[TBL] [Abstract][Full Text] [Related]
18. Functional Analysis of Porphyromonas gingivalis W83 CRISPR-Cas Systems.
Burmistrz M; Dudek B; Staniec D; Rodriguez Martinez JI; Bochtler M; Potempa J; Pyrc K
J Bacteriol; 2015 Aug; 197(16):2631-41. PubMed ID: 26013482
[TBL] [Abstract][Full Text] [Related]
19. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting.
Goldberg GW; Jiang W; Bikard D; Marraffini LA
Nature; 2014 Oct; 514(7524):633-7. PubMed ID: 25174707
[TBL] [Abstract][Full Text] [Related]
20. Cas13-induced cellular dormancy prevents the rise of CRISPR-resistant bacteriophage.
Meeske AJ; Nakandakari-Higa S; Marraffini LA
Nature; 2019 Jun; 570(7760):241-245. PubMed ID: 31142834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
